20 completed, 4 terminated, 2 unknown, 2 withdrawn. 29 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 29 | Completed 20, Terminated 4, Unknown 2, Withdrawn 2, Not yet recruiting 1 |
Follow Kidney Failure: new trials by email Literature Review of Kidney Failure trials Research Report on Kidney Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia Levocarnitine Injection, Usual ESA-Based Anemia Care - Anemia, Kidney Failure | Phase 4 | Not yet recruiting | Shaikh Zayed Hospital, Lahore | 94 | 2025-09-15 | 2025-09-12 |
| Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease Rifampicin plus Isoniazid, Rifapentine plus Isoniazid, Rifampicin alone - Latent Tuberculosis, Kidney Failure | Phase 4 | Unknown | Miguel Santín | 225 | 2024-04-20 | 2024-03-15 |
| QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir Glecaprevir and Pibrentasvir - Kidney Failure, Hepatitis C | Phase 4 | Terminated | Massachusetts General Hospital | 2 | 2021-05-01 | 2024-12-03 |
| Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia Empagliflozin 25 MG, Placebo - Hyponatremia, SIADH | Phase 4 | Completed | University Hospital, Basel, Switzerland | 113 | 2021-02-04 | 2026-09-22 |
| HCV + to HCV - Kidney Transplant Direct Acting Antivirals - Kidney Failure, Hepatitis C | Phase 4 | Withdrawn | Massachusetts General Hospital | 2020-05-21 | 2022-08-31 | |
| Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant glecaprevir/pibrentasvir tablets - Kidney Failure, Kidney Diseases | Phase 4 | Withdrawn | Raymond T. Chung, MD | 2019-02-15 | 2019-06-03 | |
| A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients Dalteparin - Kidney Failure | Phase 4 | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 15 | 2016-08-01 | 2020-02-24 |
| Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg) Thymoglobulin - Kidney Failure | Phase 4 | Unknown | Asan Medical Center | 154 | 2015-06-01 | 2015-05-19 |
| IV Antibiotics With Lavage for Severe PD Peritonitis Intravenous vancomycin & gentamicin with adjunctive lavage, Intraperitoneal vancomycin & gentamicin - Peritonitis, Kidney Failure | Phase 4 | Completed | Alice Ho Miu Ling Nethersole Hospital | 46 | 2014-03-01 | 2018-01-31 |
| Protocolized Diuretic Strategy in Cardiorenal Failure Protocolized Diuretic Strategy - Cardiac Failure, Renal Failure | Phase 4 | Terminated | Kelly V. Liang, MD | 19 | 2013-11-01 | 2017-08-21 |
| Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis Mycophenolate mofetil - Kidney Transplantation, Kidney Failure | Phase 4 | Completed | Clinical Hospital Merkur | 76 | 2013-05-01 | 2021-10-26 |
| Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol Calcitriol, Paricalcitol - Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Terminated | Winthrop University Hospital | 16 | 2012-11-01 | 2023-11-07 |
| Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients Cinacalcet, Surgical total parathyroidectomy with forearm autografting - Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Completed | The University of Hong Kong | 67 | 2010-05-10 | 2021-10-12 |
| 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy DDAVP, saline solution - Kidney Failure | Phase 4 | Completed | University of Bari | 162 | 2008-08-01 | 2015-01-13 |
| Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients cyclosporine or tacrolimus, sirolimus - Graft Rejection, Kidney Failure | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 121 | 2006-09-01 | 2011-05-30 |
| Study Evaluating Sirolimus in the Treatment of Kidney Transplant Sirolimus - Kidney Failure, Kidney Diseases | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 100 | 2006-08-01 | 2007-03-22 |
| Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Paricalcitol - Kidney Failure | Phase 4 | Completed | Fresenius Medical Care North America | 64 | 2006-03-01 | 2010-04-08 |
| CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation Campath, Daclizumab - Kidney Transplantation, Kidney Diseases | Phase 4 | Completed | EMagnusson | 123 | 2005-10-01 | 2021-09-29 |
| A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients Tacrolimus, Sirolimus, prednisone - Kidney Failure, Graft vs Host Disease | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 47 | 2005-08-01 | 2023-12-11 |
| PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography Simvastatin - Kidney Failure | Phase 4 | Completed | Seoul National University Hospital | 320 | 2005-02-01 | 2007-07-12 |
Showing 20 of 29. Sign in to see all of them.
Renal Insufficiency (29) · Graft vs Host Disease (3) · Hepatitis C (3) · Kidney Diseases (3) · Anemia (2) · Hyperparathyroidism, Secondary (2) · Kidney Failure, Chronic (2) · Renal Insufficiency, Chronic (2) · Bronchiolitis Obliterans Syndrome (1) · Cardio-Renal Syndrome (1) · Diabetes Insipidus (1) · Edema (1) · Heart Failure (1) · Hemorrhage (1) · Hypercalcemia (1)
Female Urogenital Diseases (29) · Female Urogenital Diseases and Pregnancy Complications (29) · Male Urogenital Diseases (29) · Urogenital Diseases (29) · Urologic Diseases (29) · Kidney Diseases (26) · Pathological Conditions, Signs and Symptoms (6) · Digestive System Diseases (5) · Infections (5) · Pathologic Processes (5) · Chronic Disease (4) · Disease Attributes (4) · Endocrine System Diseases (4) · Immune System Diseases (4) · Liver Diseases (4)
Sirolimus (7) · Tacrolimus (3) · Cyclosporine (2) · Mycophenolic Acid (2) · glecaprevir and pibrentasvir (2) · paricalcitol (2) · Alemtuzumab (1) · Ascorbic Acid (1) · Calcitriol (1) · Carnitine (1) · Cinacalcet (1) · Cyclosporins (1) · Daclizumab (1) · Dalteparin (1) · Deamino Arginine Vasopressin (1)
Wyeth is now a wholly owned subsidiary of Pfizer (8) · Seoul National University Hospital (3) · Massachusetts General Hospital (2) · Alice Ho Miu Ling Nethersole Hospital (1) · Asan Medical Center (1) · Austin Health (1) · Centre Hospitalier Universitaire, Amiens (1) · Clinical Hospital Merkur (1) · EMagnusson (1) · Fresenius Medical Care North America (1) · Kelly V. Liang, MD (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Miguel Santín (1) · Raymond T. Chung, MD (1) · Shaikh Zayed Hospital, Lahore (1)
United States (6) · South Korea (3) · Australia (2) · Brazil (2) · Canada (2) · Hong Kong (2) · Spain (2) · Switzerland (2) · Austria (1) · Croatia (1) · France (1) · Germany (1) · India (1) · Italy (1) · Mexico (1)
Byung-Hee Oh, M.D., Ph.D. (3) · Sang-Ho Jo, M.D. (3) · Hyo-Soo Kim, M.D.,Ph.D. (2) · Adam G McLean, FRCP, DPhil (1) · Angela YM Wang, MD, PhD (1) · Bon-Kwon Koo, M.D., Ph.D. (1) · Bon-Kwon Koo, M.D.,Ph.D. (1) · Carlo Manno, MD (1) · David A Story, MD (1) · David H Taube, MBBCh, FRCP (1) · Franck Martinez, MD, PhD (1) · Gabriel Choukroun, MD, PhD (1) · Hyo-Soo Kim, M.D., Ph.D. (1)
PMID 16949481, PMID 18294484, PMID 21354681, PMID 21836540, PMID 22193388, PMID 22776430, PMID 36269714, PMID 36791280, PMID 36857393, PMID 36869794, PMID 38040277, PMID 39382091
2005 (1)